Pharmaceuticals

Personalized Medicine Market Forecast: What to Expect by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Personalized Medicine Market From 2025 To 2034?

The personalized medicine market has shown robust expansion over recent years. Its valuation is anticipated to climb from $386.27 billion in 2024 to $422.9 billion by 2025, representing a compound annual growth rate (CAGR) of 9.5%. This historical upward trend is attributable to the emergence of companion diagnostics, a focus on patient-centric healthcare, a paradigm shift in drug development, strategies for healthcare cost containment, and the rising prevalence of chronic diseases.

The personalized medicine market size is anticipated to experience substantial growth in the coming years. It is projected to reach $650.59 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.4%. This expansion during the forecast period is largely attributable to ongoing genomic advancements, the broadening of biomarker discovery, increased adoption of telemedicine, supportive regulatory frameworks, and enhanced collaboration and data sharing. Furthermore, significant trends expected in this period encompass the integration of artificial intelligence (AI), continued advancements in genomic sequencing, robust data integration and analytics, the emergence of immunotherapy and targeted therapies, and greater patient empowerment alongside informed decision-making, as well as strengthened collaborations and partnerships.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Are The Top Growth Drivers Impacting The Personalized Medicine Market Outlook?

The increasing occurrence of rare diseases is anticipated to propel the expansion of the personalized medicine market. This surge signifies a growing count of individuals diagnosed with conditions like Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides customized treatment solutions, catering to the distinct requirements of those with rare diseases. As an illustration, data from February 2024, sourced from the Genetic Alliance UK, a UK-based national charity supporting people affected by genetic, rare and undiagnosed conditions, indicates that in the UK, 3.5 million people currently live with a rare condition, and throughout their lives, 1 in 17 individuals will encounter a rare condition. Consequently, as the prevalence of rare diseases continues to escalate, it is energizing the growth of the personalized medicine market.

What Are The Major Segment Categories Driving The Personalized Medicine Market Growth?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What Are The Major Trends Driving The Growth Of The Personalized Medicine Market?

The personalized medicine market is seeing technological advancements emerge as a key trend gaining significant popularity. Major companies within this market are adopting new technologies to sustain their competitive standing. For instance, in April 2023, OM1, a US-based healthcare company utilizing real-world data and artificial intelligence (AI) to assist healthcare providers, patented an AI-powered platform to accelerate personalized medicine. This technology employs large-scale data analysis to generate meaningful insights into diagnoses, disease progression, and treatment responses. Its importance stems from providing tailored healthcare inputs, enhancing informed decision-making for healthcare providers, and expediting clinical trials by efficiently identifying suitable candidates, all contributing to the advancement of personalized medicine in the market.

Which Industry Leaders Are Driving Innovation Across The Personalized Medicine Market?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Personalized Medicine Market?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

Browse Through More Reports Similar to the Global Personalized Medicine Market 2025, By The Business Research Company

Paints And Coatings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/paints-and-coatings-global-market-report

Surface Active Agents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/surface-active-agents-global-market-report

Synthetic Pigments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-pigments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795